{"id":66855,"date":"2025-03-12T10:13:57","date_gmt":"2025-03-12T10:13:57","guid":{"rendered":"https:\/\/www.accely.com\/?post_type=news&p=66855"},"modified":"2025-04-28T10:35:52","modified_gmt":"2025-04-28T10:35:52","slug":"us-based-biotechnology-research-company-integrates-raapyd-icr-software","status":"publish","type":"news","link":"https:\/\/demo.accely.com\/gb-en\/news\/us-based-biotechnology-research-company-integrates-raapyd-icr-software\/","title":{"rendered":"US-based Biotechnology Research Company Integrates Raapyd’s Intelligent Character Recognition Software"},"content":{"rendered":"\n
\n
\n
\n
\n

US-based Biotechnology Research Company Integrates Raapyd’s Intelligent Character Recognition Software<\/h1>\n
\n United States<\/span>\n <\/div>\n

Published: March 12, 2025<\/p>\n \n \n\n\n\n <\/div>\n

\n \"Banner\"\n <\/div>\n <\/div>\n <\/div>\n<\/section>\n\n\n
\n
\n
\n

In a strategic move to enhance data processing efficiency and streamline documentation workflows, a world-renowned biotechnology research company in the United States has successfully integrated Intelligent Character Recognition (ICR) software from Raapyd, an Accely subsidiary company.<\/p>\n

Specializing in cutting-edge research and innovation, the company handles massive volumes of handwritten, scanned, and semi-structured data across clinical trials, lab reports, and regulatory documentation.<\/p>\n

Addressing Critical Challenges<\/h2>\n

While accelerating life science research and providing life-changing therapies, the company faced several critical challenges in managing large volumes of unstructured and handwritten data. Manual data entry processes were time-consuming and resource-intensive, often leading to delays in research timelines.<\/p>\n

Our Strategic Approach<\/h2>\n

Comprehensive Process Assessment: <\/b>Conducted an in-depth assessment of the company\u2019s data processing workflows, identifying bottlenecks in manual data entry, document variability, and compliance gaps across research and regulatory functions.<\/p>\n

Deployment of Raapyd\u2019s AI-powered ICR Engine: <\/b>Implemented Raapyd\u2019s Intelligent Character Recognition software<\/a> to automate the capture and interpretation of handwritten, scanned, and semi-structured documents.<\/p>\n

Customization for Scientific Data: <\/b>Accely fine-tuned the ICR solution to recognize and adapt to complex scientific terms, symbols, and multilingual inputs often found in biotech research documentation, enhancing contextual accuracy.<\/p>\n

Workflow Automation and Standardization: <\/b>By automating document classification, data indexing, and approval workflows, we reduced dependency on manual intervention and standardized the process for regulatory readiness.<\/p>\n

By eliminating manual data processing bottlenecks, improving accuracy, and ensuring compliance, the company has accelerated its research efficiency and operational agility. As the parent company of Raapyd and a leading digital transformation and consulting service provider<\/a>, Accely played a critical role in driving this transformation, providing strategic oversight, seamless implementation, and ongoing support to ensure measurable results.<\/p>\n <\/div>\n <\/div>\n<\/section>\n\n

\n
\n
\n
\n <\/div> \n <\/div>\n <\/div>\n<\/section>\n\n
\n
\n
\n
\n
\n \"Profile\"\n
\n

Accely Group<\/p>\n

Official News & Media Team<\/p>\n \n \n <\/div>\n <\/div>\n \n